Solana treasury company Artelo Biosciences completes $3 million rights issue
2025-09-09 08:24:27
Nasdaq-listed Solana treasury company Artelo Biosciences announced the issuance of 640,924 common shares to the public at a price of $4.40 per share, raising a total of approximately $3 million. Artelo Biosciences is a clinical pharmaceutical company that has previously announced the official launch of a Solana-based digital asset treasury strategy and will invest part of its capital in the purchase of SOL tokens. As of now, it holds 45,883 SOL.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
Solana财库公司Artelo Biosciences完成300万美元配股募资Next article：
知情人士：日本央行Q4或小幅减少超长期日本国债购买量
